Radiation-related toxicities and outcomes in endometrial cancer: are obese women at a disadvantage?

[1] Colombo N(2013)Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 24 vi33-vi38

[2] Preti E(2010)Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 816-823

[3] Landoni F(2000)Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma Lancet 355 1404-1411

[4] Nout RA(2004)A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 744-751

[5] Smit VT(2009)Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis Lancet 373 137-146

[6] Putter H(2015)Radiation-associated toxicities in obese women with endometrial cancer: more than just BMI? Scientific World J 2015 483208-1288

[7] Creutzberg CL(2012)External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study–quality-of-life analysis Int J Gynecol Cancer 22 1281-133

[8] van Putten WL(2014)Adjuvant radiotherapy for endometrial cancer–a comparative review of radiotherapy technique with acute toxicity Eur J Gynaecol Oncol 35 128-141

[9] Koper PC(2014)The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? Gynecol Oncol 132 137-46

[10] Keys HM(2015)Global burden of cancer attributable to high body-mass index in 2012: a population-based study Lancet Oncol 16 36-1172

[1] Colombo N(2013)Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 24 vi33-vi38

[2] Preti E(2010)Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 816-823

[3] Landoni F(2000)Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma Lancet 355 1404-1411

[4] Nout RA(2004)A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 744-751

[5] Smit VT(2009)Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis Lancet 373 137-146

[6] Putter H(2015)Radiation-associated toxicities in obese women with endometrial cancer: more than just BMI? Scientific World J 2015 483208-1288

[7] Creutzberg CL(2012)External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study–quality-of-life analysis Int J Gynecol Cancer 22 1281-133

[8] van Putten WL(2014)Adjuvant radiotherapy for endometrial cancer–a comparative review of radiotherapy technique with acute toxicity Eur J Gynaecol Oncol 35 128-141

[9] Koper PC(2014)The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? Gynecol Oncol 132 137-46

[10] Keys HM(2015)Global burden of cancer attributable to high body-mass index in 2012: a population-based study Lancet Oncol 16 36-1172